Monday, May 23, 2016
Europe lifts warning on Pfizer smoking cessation drug
LONDON (Reuters) - European regulators have lifted a warning on Pfizer's smoking cessation drug Champix - called Chantix in the United States - after a clinical study concluded it did not appear to increase the risk of neuropsychiatric side effects.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment